Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - toltrazuril - oral suspension - 50 milligram(s)/millilitre - toltrazuril - cattle, pigs, sheep - coccidiostats

United Kingdom - English - VMD (Veterinary Medicines Directorate)

krka d.d., novo mesto - toltrazuril - oral suspension - antiprotozoal anticoccidial - cattle, pigs, sheep

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - toltrazuril - oral suspension - 50 mg/ml - toltrazuril - bovine, ovine, porcine - coccidiostats

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - toltrazuril 50 mg/ml - oral suspension - 50 mg/ml - toltrazuril 50 mg/ml - toltrazuril - pig; cattle; sheep

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - ointment - 3.5 mg in 1 g - stratol ophthalmic ointment is indicated in the topical treatment of infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis, and keratoconjunctivitis, blepharitis and blepharoconjunctivitis, acute meibomianitis and dacryocystitis. epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and many other viral diseases of the cornea and conjunctiva. mycobacterial infection of the eye. fungal diseases of ocular structures. hypersensitivity to a component of the medication.

United States - English - NLM (National Library of Medicine)

alcon - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - solution - 3.5 mg in 1 ml - stratol ophthalmic solution is indicated in the topical treatment of infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis, and keratoconjunctivitis, blepharitis and blepharoconjunctivitis, acute meibomianitis and dacryocystitis. epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and many other viral diseases of the cornea and conjunctiva. mycobacterial infection of the eye. fungal diseases of ocular structures. hypersensitivity to a component of the medication.

Canada - English - Health Canada

hoffmann-la roche limited - ceftriaxone (ceftriaxone sodium) - powder for solution - 250mg - ceftriaxone (ceftriaxone sodium) 250mg - third generation cephalosporins

Canada - English - Health Canada

hoffmann-la roche limited - ceftriaxone (ceftriaxone sodium) - powder for solution - 2g - ceftriaxone (ceftriaxone sodium) 2g - third generation cephalosporins

Canada - English - Health Canada

hoffmann-la roche limited - ceftriaxone (ceftriaxone sodium) - powder for solution - 1g - ceftriaxone (ceftriaxone sodium) 1g - third generation cephalosporins

Canada - English - Health Canada

hoffmann-la roche limited - ceftriaxone (ceftriaxone sodium) - powder for solution - 10g - ceftriaxone (ceftriaxone sodium) 10g - third generation cephalosporins